tiprankstipranks
Trending News
More News >
Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX
US Market

Lineage Therap (LCTX) Financial Statements

Compare
2,044 Followers

Lineage Therap Financial Overview

Lineage Therap's market cap is currently $393.86M. The company's EPS TTM is $-0.13; its P/E ratio is ―; Lineage Therap is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Lineage Therap Earnings and Revenue History

Lineage Therap Debt to Assets

Lineage Therap Cash Flow

Lineage Therap Forecast EPS vs Actual EPS